On the MedCity Pivot podcast, host Arundhati Parmar talks with Dr. Iftach Dolev, neuroscientist and CEO of QuantalX, about Delphi-MD™ and the FDA De Novo classification of the system.
Topics covered
- Why routine clinical care has few tools to measure how the brain functions, compared with imaging that shows brain structure.
- How Delphi-MD™ combines transcranial magnetic stimulation and EEG in one bedside system, controlled by software from acquisition to the report.
- Who uses it: the indication is for brain specialists, with interpretation by a neurologist or psychiatrist and operation by a medical technician.
- How results are compared with a normative database for ages 50 to 75 and how the assessment fits alongside cognitive tests and MRI or CT.
- How centers are using the system, from rehabilitation and chronic pain studies to healthy aging programs, and the dedicated reimbursement code for the procedure.
Video by MedCity News. The episode page, with audio and the full conversation, is available on MedCity News.
Bring brain function data into your practice
Talk to the QuantalX team about Delphi-MD™ in your clinical setting.
Request a demo